GE Healthcare Life Sciences
Pollards Wood
Nightingales Lane
Chalfont St. Giles
Buckinghamshire
HP8 4SP
United Kingdom
Tel: 44-1494-544-000
Website: http://www.gehealthcare.com/
569 articles about GE Healthcare Life Sciences
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 28, 2020.
-
Avacta Successfully Generates Several Highly Specific Affimer Reagents for COVID-19 Antigen Rapid Test Ahead of Schedule as Part of Cytiva Partnership
4/22/2020
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that, in only four weeks and well ahead of schedule, it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen as part of its collaboration with Cytiva to develop an Affimer-based rapid test for the COVID-19 coronavirus infection.
-
Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences
3/19/2020
Danaher Corporation announced that the U.S. Federal Trade Commission has accepted the proposed consent order in connection with Danaher's definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences.
-
BioSpace Global Roundup: Feb. 6
2/6/2020
Pharma and life science companies from across the globe provide updates on their pipelines and businesses. -
GE Healthcare Life Sciences pairs up with Advanced Solutions Life Sciences to create new opportunities for regenerative tissue manufacturing
12/8/2019
GE Healthcare Life Sciences and Advanced Solutions Life Sciences will enter into a strategic R&D and distribution partnership that sets out to personalize tissue regeneration.
-
The new facility, which could be open by the end of 2021, will be supported by Harvard University, Massachusetts Institute of Technology, GE Healthcare Life Sciences, Alexandria Real Estate Equities and FUJIFILM Diosynth Biotechnologies.
-
Mind the talent gap: new biologics facility to upskill future workforce
7/24/2019
The opening of a new $11.5m biotech production and training facility at the University of Technology Sydney has been welcomed by government and industry leaders who say fostering and keeping local talent in the burgeoning Life Sciences sector is key to building a globally competitive industry.
-
GE and NVIDIA Join Forces to Accelerate Artificial Intelligence Adoption in Healthcare
11/27/2017
The new CT system in the Revolution Family is two times faster in imaging processing than its predecessor, due to its use of NVIDIA’s AI computing platform.
-
Bernoulli Health Collaborates With GE Healthcare to Enable Interoperability
11/14/2017
Bernoulli Health announced today collaboration with GE Healthcare on the new CARESCAPE Connect data aggregation solution.
-
Blue Earth Diagnostics And GE Healthcare Sign UK Manufacturing Agreement
10/2/2017
-
GE Healthcare Launches First-Ever Mammography System That Allows Patients To Control Their Compression By Remote Control
9/6/2017
-
GE Healthcare Advances The Delivery Of Cell Therapies With New Thawing Technology
9/5/2017
-
ARTMS Products And GE Healthcare Team Up To Expand Cyclotron Produced Radioisotopes And Address Longstanding Radiopharmaceutical Supply Concerns In Medical Imaging
8/29/2017
-
GE Healthcare's SIGNA Premier Cleared by the U.S. FDA
8/7/2017
-
British Biotech Horizon Discovery Pays $85 Million for GE Healthcare's Gene-Editing Biz
7/19/2017
-
GE Healthcare Partners With Oritain To Introduce Independent Test To Confirm Country Of Origin Of Fetal Bovine Serum
7/11/2017
-
NIBRT And GE Healthcare To Drive Next-Generation Biomanufacturing Competence With A New Training Center
6/8/2017
-
GE Healthcare Release: Next Generation IN Cell High Content Analysis Solutions Featuring New IN Carta Image Analysis Software
6/6/2017
-
GE Healthcare With Harvard Hospitals To Harness AI In Medicine
5/19/2017
-
GE Healthcare’s FlexFactory To Power Dr. Reddy's Laboratories Ltd.’s Biosimilar Expansion Plans
5/18/2017